Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 4 28-4, 2003, Pages

  Mukaida, Naofumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Chemokine; Inflammation; Neutrophil

Indexed keywords

ALPHA CHEMOKINE; INTERLEUKIN 8;

ALLERGY; ASTHMA; BACTERIAL INFECTION; HUMAN; LUNG CANCER; LUNG DISEASE; LUNG FIBROSIS; LUNG INJURY; LUNG TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW; VIRUS INFECTION;

EID: 0037377567     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00233.2002     Document Type: Review

References (169)

1. Abe S, Nakamura H, Inoue S, Takeda H, Saito H, Kato S, Mukaida N, Matsushima K, and Tomoike H. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. Am J Respir Cell Mol Biol 22: 51-60, 2000.
2. Addison CL, Arenberg DA, Morris SB, Xue YY, Burdick MD, Mulligan MS, Iannettoni MD, and Strieter RM. The CXC chemokine, monokine induced by interferon-γ, inhibits non-small cell lung carcinoma tumor growth and metastasis. Hum Gene Ther 11: 247-261, 2000.
3. Aggarwal A, Baker CS, Evans TW, and Haslam PL. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J 15: 895-901, 2000.
4. Ahuja SK and Murphy PM. The CXC chemokines growth-regulated oncogene (GRO) α, GROβ, GROγ, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271: 20545-20550, 1996.
5. Aihara M, Tsuchimoto D, Takizawa H, Azuma A, Wakebe H, Ohmoto Y, Imagawa K, Kikuchi M, Mukaida N, and Matsushima K. Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun 65: 3218-3224, 1997.
6. Alcorn MJ, Booth JL, Coggeshall KM, and Metcalf JP. Adenovirus type 7 induces interleukin-8 production via activation of extracellular regulated kinase 1/2. J Virol 75: 6450-6459, 2001.
7. Allen GL, Menendez IY, Ryan MA, Mazor RL, Wispe JR, Fiedler MA, and Wong HR. Hyperoxia synergistically increase TNF-α-induced interleukin-8 gene expression in A549 cells. Am J Physiol Lung Cell Mol Physiol 278: L253-L260, 2000.
8. Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, and Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 182: 155-162, 1995.
9. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, and Strieter RM. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 97: 2792-2802, 1996.
10. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, and Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385: 296-297, 1997.
11. Bacon KB, Flores-Romo L, Aubry JP, Wells TN, and Power CA. Interleukin-8 and RANTES induce the adhesion of the human basophilic cell line KU-812 to human endothelial cell monolayers. Immunology 82: 473-481, 1994.
12. Baggiolini M, Dewald B, and Moser B. Human chemokines: an update. Annu Rev Immunol 15: 675-705, 1997.
13. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri EA, and Gerhengorn MC. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391: 86-89, 1998.
14. Baldwin ET, Weber IT, St. Charles R, Xuan JC, Appella E, Yamada M, Matsushima K, Edwards BF, Clore GM, Gronenborn AM, and Wlodawer A. Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci USA 88: 502-506, 1991.
15. Balish E, Wagner RD, Vazquez-Torres A, Jones-Carson J, Pierson C, and Warner T. Mucosal and systemic candidiasis in IL-8Rh-/- BALB/c mice. J Leukoc Biol 66: 144-150, 1999.
16. Barnes PJ. Novel approaches and targets for treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: S72-S79, 1999.
17. Bellocq A, Antoine M, Flahault A, Philippe C, Crestani B, Bernaudin JF, Mayaud C, Milleron B, Baud L, and Cadranel J. Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol 152: 83-92, 1998.
18. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, and Strieter RM. CXC chemokines in angiogenesis. J Leukoc Biol 68: 1-8, 2000.
19. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, and Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial co-ordination. Am J Respir Crit Care Med 149: 818-824, 1994.
20. Bischoff SC, Baggiolini M, de Weck AL, and Dahinden CA. Interleukin-8 inhibitor and inducer of histamine and leukotriene release in human basophils. Biochem Biophys Res Commun 179: 628-633, 1991.
21. Bowman EP, Campbell JJ, Druey KM, Scheschonka A, Kehrl JH, and Butcher EC. Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. J Biol Chem 273: 28040-28048, 1998.
22. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, and Christmas SE. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12: 78-85, 2000.
23. Broaddus VC, Boylan AM, Hoeffel JM, Kim KJ, Sadick M, Chuntharapai A, and Hebert CA. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol 152: 2960-2967, 1994.
24. Bruijnzeel PL, Kuijper PH, Rihs S, Betz S, Warringa RA, and Koenderman L. Eosinophil migration in atopic dermatitis. I. Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4. J Invest Dermatol 100: 137-142, 1993.
25. Burger M, Burger JA, Hoch RC, Oades Z, Takamori H, and Schraufstatter IU. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor. J Immunol 163: 2017-2022, 1999.
26. Burns AR, Simon SI, Kukielka GL, Rowen JL, Mendoza LH, Brown ES, Entman ML, and Smith CW. Chemotactic factors stimulate CD18-dependent canine neutrophil adherence and motility on lung fibroblasts. J Immunol 156: 3389-3401, 1996.
27. Burrows SD, Doyle ML, Murphy KP, Franklin SG, White JR, Brooks I, McNulty DE, Scott MO, Knutson JR, Porter D, Young PR, and Hensley P. Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. Biochemistry 33: 12741-12745, 1994.
28. Bussolino F, Sironi M, Bocchietto E, and Mantovani A. Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8. J Biol Chem 267: 14598-14603, 1992.
29. Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, Wood WI, and Moore MW. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265: 682-684, 1994.
30. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, and Walz A. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 149: 655-659, 1994.
31. Carre PC, Mortenson RL, King TE Jr, Noble PW, Sable CL, and Riches DW. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest 88: 1802-1810, 1991.
32. Carveth HJ, Bohnsack JF, McIntyre TM, Baggiolini M, Prescott SM, and Zimmerman GA. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem Biophys Res Commun 162: 387-393, 1989.
33. Casola A, Garfalo RP, Jamulddin M, Vlahopoulos S, and Brasier AR. Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression. J Immunol 164: 5944-5951, 2000.
34. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, and Oppenheim JJ. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 271: 2935-2940, 1996.
35. Chuntharapai A and Kim KJ. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol 155: 2587-2594, 1994.
36. Chuntharapai A, Lee J, Hebert CA, and Kim KJ. Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 153: 5682-5688, 1994.
37. Czuprynski CJ, Brown JF, Steinberg H, and Carroll D. Mice lacking the murine interleukin-8 receptor homologue demonstrate paradoxical responses to acute and chronic experimental infection with Listeria monocytogenes. Microb Pathog 24: 17-23, 1998.
38. Dahinden CA, Kurimoto Y, De Weck AL, Lindley I, Dewald B, and Baggiolini M. The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin-3-primed basophils. J Exp Med 170: 1787-1792, 1989.
39. D'Angio CT, LoMonaco MB, Chaudhry SA, Paxhia A, and Ryan RM. Discordant pulmonary proinflammatory cytokine expression during acute hyperoxia in the newborn rabbit. Exp Lung Res 25: 443-465, 1999.
40. Deng H, Mason SN, and Auten RL. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 162: 2316-2323, 2000.
41. De Perrot M, Sekine Y, Fischer S, Waddell TK, McRae K, Liu M, Wigle DA, and Keshavjee S. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 165: 211-215, 2002.
42. De Sanctis GT, MacLean JA, Qin S, Wolyniec WW, Grasemann H, Yandava CN, Jiao A, Noonan T, Stein-Streilein J, Green FH, and Drazen JM. Interleukin-8 receptor modulates IgE production and B-cell expansion and trafficking in allergen-induced pulmonary inflammation. J Clin Invest 103: 507-515, 1999.
43. Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, and Cohn ZA. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 171: 1155-1162, 1990.
44. DiMango E, Zar HJ, Bryan R, and Prince A. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 96: 2204-2210, 1995.
45. Djeu JY, Matsushima K, Oppenheim JJ, Shiotsuki K, and Blanchard DK. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/ IL-8. J Immunol 144: 2205-2210, 1990.
46. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, and Haslett C. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341: 643-647, 1993.
47. Druey KM, Blumer KJ, Kang VH, and Kehrl JH. Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 379: 742-746, 1996.
48. Dunican AL, Leuenroth SJ, Grutkoski P, Ayala A, and Simms HH. TNF-α-induced suppression of PMN apoptosis is mediated through interleukin-8 production. Shock 14: 284-288, 2000.
49. Dunlevy JR and Couchman JR. Interleukin-8 induces motile behavior and loss of focal adhesions in primary fibroblasts. J Cell Sci 108: 311-321, 1995.
50. Emi M, Keicho N, Tokunaga K, Katsumata H, Souma S, Nakata K, Taguchi Y, Ohishi N, Azuma A, and Kudoh S. Association of diffuse panbronchiolitis with microsatellite polymorphism of the human interleukin 8 (IL-8) gene. J Human Genet 44: 169-172, 1999.
51. Engler RL, Dahlgren MD, Morris DD, Peterson MA, and Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol Heart Circ Physiol 251: H314-H323, 1986.
52. Erger RA and Casale TB. Interleukin-8 plays a significant role in IgE-mediated lung inflammation. Eur Respir J 11: 299-305, 1998.
53. Folkesson HG, Matthay MA, Hebert CA, and Broaddus VC. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 96: 107-116, 1995.
54. Frendeus B, Godaly G, Hang L, Karpman D, Lundstedt AC, and Svanborg C. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 192: 881-890, 2000.
55. Friedl HP, Smith DJ, Till GO, Thomson PD, Louis DS, and Ward PA. Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity. Am J Pathol 136: 491-495, 1990.
56. Friedland JS, Suputtamongkol Y, Remick DG, Chaowagul W, Strieter RM, Kunkel SL, White NJ, and Griffin GE. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 60: 2402-2408, 1992.
57. Fujimura M, Myou S, Nomura M, Mizuguchi M, Matsuda T, Harada A, Mukaida N, Matsushima K, and Nonomura A. Interleukin-8 inhalation directly provokes bronchoconstriction in guinea pigs. Allergy 54: 386-391, 1999.
58. Geiser T, Dewald B, Ehrengruber MU, Clark-Lewis I, and Baggiolini M. The interleukin-8-related chemotactic cytokines GRO-α, GRO-β, and GRO-γ activate human neutrophil and basophil leukocytes. J Biol Chem 268: 15419-15424, 1993.
59. Geras-Raaka E, Varma A, Ho H, Clark-Lewis I, and Gershengorn MC. Human interferon-γ-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Exp Med 188: 405-408, 1998.
60. Gershengorn MC, Geras-Raaka E, Varma A, and Clark-Lewis I. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest 102: 1469-1472, 1998.
61. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, and Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718-723, 1999.
62. Gibson PG, Simpson JL, and Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119: 1299-1300, 2001.
63. Godaly G, Hang L, Frendeus B, and Svanborg C. Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J Immunol 165: 5287-5294, 2000.
64. Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, and Aarden LA. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60: 2835-2842, 1992.
65. Hebert CA, Luscinskas FW, Kiely JM, Luis EA, Darbonne WC, Bennett GL, Liu CC, Obin MS, Gimbrone MA Jr, and Baker JB. Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J Immunol 145: 3033-3040, 1990.
66. Hill AT, Bayley D, and Stockley RA. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med 160: 893-898, 1999.
67. Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, and Wymann MP. Central role for G protein-coupled phosphoinositide 3-kinase-γ in inflammation. Science 287: 1049-1053, 2000.
68. Holmes WE, Lee J, Kuang WJ, Rice GC, and Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science 253: 1278-1280, 1991.
69. Horgan MJ, Wright SD, and Malik AB. Antibody against leukocyte integrin (CD18) prevents reperfusion-induced lung vascular injury. Am J Physiol Lung Cell Mol Physiol 259: L315-L319, 1990.
70. Huber AR, Kunkel SL, Todd III RF, and Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254: 99-102, 1991.
71. Iguchi A, Kitajima I, Yamakuchi M, Ueno S, Aikou T, Kubo T, Matsushima K, Mukaida N, and Maruyama I. PEA3 and AP-1 are required for constitutive IL-8 gene expression in hepatoma cells. Biochem Biophys Res Commun 279: 166-171, 2000.
72. Ikeda N, Mukaida N, Kaneko S, Fujioka N, Su S, Nariuchi H, Unoura M, Harada K, Nakanuma Y, Kobayashi K, and Matsushima K. Prevention of endotoxin-induced acute lethality in Propionibacterium acnes-primed rabbits by an antibody to leukocyte integrin beta 2 with concomitant reduction of cytokine production. Infect Immun 63: 4812-4817, 1995.
73. Janssen-Heininger YM, Poynter ME, and Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic Biol Med 28: 1317-1327, 2000.
74. Jinquan T, Moller B, Storgaard M, Mukaida N, Bonde J, Grunnet N, Black FT, Larsen CG, Matsushima K, and Thestrup-Pedersen K. Chemotaxis and IL-8 receptor expression in B cells from normal and HIV-infected subjects. J Immunol 158: 475-484, 1997.
75. Johnston SL, Papi A, Monick MM, and Hunninghake GW. Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. J Infect Dis 175: 323-329, 1997.
76. Jones SA, Wolf M, Qin S, Mackay CR, and Baggiolini M. Different functions for the interleukin-8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci USA 93: 6682-6686, 1996.
77. Keane MP, Arenberg DA, Lynch III JP, Whyte RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, Kunkel SL, and Strieter RM. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 159: 1437-1443, 1997.
78. Keane MP, Belperio JA, Arenberg DA, Burdick MD, Xu ZJ, Xue YY, and Strieter RM. IFN-γ-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 163: 5686-5692, 1999.
79. Keane MP, Belperio JA, Moore TA, Moore BB, Arenberg DA, Smith RE, Burdick MD, Kunkel SL, and Strieter RM. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J Immunol 162: 5511-5518, 1999.
80. Khabar KS, Al-Zoghaibi F, Al-Ahdal MN, Murayama T, Dhalla M, Mukaida N, Taha M, Al-Sedairy ST, Siddiqui Y, Kessie G, and Matsushima K. The α-chemokine, interleukin 8, inhibits the antiviral action of interferon-α. J Exp Med 186: 1077-1085, 1997.
81. Kimata H, Lindley I, and Furusho K. Selective inhibition of spontaneous IgE and IgG4 production by interleukin-8 in atopic patients. Blood 85: 3191-3198, 1995.
82. Kimata H, Yoshida A, Ishioka C, Lindley I, and Mikawa H. Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells. J Exp Med 176: 1227-1231, 1992.
83. Kitadai Y, Haruma K, Mukaida N, Ohmoto Y, Matsutani N, Yasui W, Yamamoto S, Sumii K, Kajiyama G, Fidler IJ, and Tahara E. Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Cancer Res 6: 2735-2740, 2000.
84. Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, Yasui W, Ohmoto Y, Kajiyama G, Fidler IJ, and Tahara E. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 152: 93-100, 1998.
85. Knall C, Young S, Nick JA, Buhl AM, Worthen GS, and Johnson GL. Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J Biol Chem 271: 2832-2838, 1996.
86. Ko YC, Mukaida N, Ishiyama S, Tokue A, Kawai T, Matsushima K, and Kasahara T. Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect Immun 61: 1307-1314, 1993.
87. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, and Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801, 1992.
88. Koga T. Neutrophilia and high level of interleukin 8 in the bronchoalveolar lavage fluid of diffuse panbronchiolitis. Kurume Med J 40: 139-146, 1993.
89. Korthuis RJ, Grisham MB, and Granger DN. Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am J Physiol Heart Circ Physiol 254: H823-H827, 1988.
90. +) T lymphocyte recruitment into subcutaneous tissues of rats by selective depletion of in vivo neutrophils with a monoclonal antibody. J Immunol 147: 2196-2201, 1991.
91. Kukielka GL, Smith CW, LaRosa GJ, Manning AM, Mendoza LH, Daly TJ, Hughes BJ, Youker KA, Hawkins HK, Michael LH, Rot A, and Entman ML. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 95: 89-103, 1995.
92. Kuna P, Reddigari SR, Kornfeld D, and Kaplan AP. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. J Immunol 147: 1920-1924, 1991.
93. Kunz M, Hartmann A, Flory E, Toksoy A, Koczan D, Thiesen HJ, Mukaida N, Neumann M, Rapp UR, Brocker EB, and Gillitzer R. Anoxia-induced upregulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am J Pathol 155: 753-763, 1999.
94. Kurashima K, Mukaida N, Fujimura M, Schroder JM, Matsuda T, and Matsushima K. Increase of chemokine levels in sputum precedes exacerbation of acute asthma attacks. J Leukoc Biol 59: 313-316, 1996.
95. Kurdowska A, Nobel JM, Steinberg KP, Ruzinski JT, Hudson LD, and Martin TR. Anti-interleukin-8 autoantibody: interleukin-8 complexes in the acute respiratory distress syndrome. Relationship between complexes and clinical disease activity. Am J Respir Crit Care Med 163: 463-468, 2001.
96. Laffon M, Pittet JF, Modelska K, Matthay MA, and Young DM. Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits. Am J Respir Crit Care Med 160: 1443-1449, 1999.
97. Lamblin C, Gosset P, Tillie-Leblond I, Saulnier F, Marquette CH, Wallaert B, and Tonnel AB. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 157: 394-402, 1998.
98. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, and Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243: 1464-1466, 1989.
99. Lee LF, Hellendall RP, Wang Y, Haskill JS, Mukaida N, Matsushima K, and Ting JP. IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration. J Immunol 164: 2769-2775, 2000.
100. Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV, and Wu D. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science 287: 1046-1049, 2000.
101. Lira SA, Fuentes ME, Strieter RM, and Durham SK. Transgenic methods to study chemokine function in lung and central nervous system. Methods Enzymol 287: 304-318, 1997.
102. Loukinova E, Dong G, Enamorado-Ayalya I, Thomas GR, Chen Z, Schreiber H, and Van Waes C. Growth regulated oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene 19: 3477-3486, 2000.
103. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338: 436-445, 1998.
104. Luster AD, Greenberg SM, and Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 182: 219-231, 1995.
105. Mahe Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, and Murakami S. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem 266: 13759-13763, 1991.
106. Martich GD, Danner RL, Ceska M, and Suffredini AF. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J Exp Med 173: 1021-1024, 1991.
107. Mastronarde JG, Monick MM, Mukaida N, Matsushima K, and Hunninghake GW. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-κB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis 177: 1275-1281, 1998.
108. Matsumoto T, Ikeda K, Mukaida N, Harada A, Matsumoto Y, Yamashita J, and Matsushima K. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab Invest 77: 119-125, 1997.
109. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Appella E, Kung HF, Leonard EJ, and Oppenheim JJ. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 169: 1485-1490, 1988.
110. McCord JM. Oxygen-derived radicals: a link between reperfusion injury and inflammation. Fed Proc 46: 2402-2406, 1987.
111. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, Auer M, Hub E, and Rot A. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91: 385-395, 1997.
112. Modelska K, Pittet JF, Folkesson HG, Courtney Broaddus V, and Matthay MA. Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. Am J Respir Crit Care Med 160: 1450-1456, 1999.
113. Mori N, Mukalda N, Ballard DW, Matsushima K, and Yamamoto N. Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-κB-like sites. Cancer Res 58: 3993-4000, 1998.
114. Morohashi H, Miyawaki T, Nomura H, Kuno K, Murakami S, Matsushima K, and Mukaida N. Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J Leukoc Biol 57: 180-187, 1995.
115. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72: 391-398, 2000.
116. Mukaida N, Harada A, Yasumoto K, and Matsushima K. Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8), and monocyte chemotactic and activating factor (MCAF). Microbiol Immunol 36: 773-789, 1992.
117. Mul FP, Zuurbier AE, Calafat J, van Westering S, Hiemstra PS, Roos D, and Horidijk PL. Sequential migration of neutrophils across monolayers of endothelial and epithelial cells. J Leukoc Biol 68: 529-537, 2000.
118. Murayama T, Kuno K, Jisaki F, Obuchi M, Sakamuro D, Furukawa T, Mukaida N, and Matsushima K. Enhancement of human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. J Virol 68: 7582-7585, 1994.
119. Murayama T, Ohara Y, Obuchi M, Khabar KS, Higashi H, Mukaida N, and Matsushima K. Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-κB-binding sites of the interleukin-8 gene. J Virol 71: 5692-5695, 1997.
120. Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol Rev 177: 175-184, 2000.
121. Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12: 593-633, 1994.
122. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, and Power CA. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52: 145-176, 2000.
123. Murphy PM and Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253: 1280-1283, 1991.
124. Nakagawa H, Hatakeyama S, Ikesue A, and Miyai H. Generation of interleukin-8 by plasmin from AVLPR-interleukin-8, the human fibroblast-derived neutrophil chemotactic factor. FEBS Lett 282: 412-414, 1991.
125. Nakamura M, Fujishima S, Sawafuji M, Ishizaka A, Oguma T, Soejima K, Matubara H, Tasaka S, Kikuchi K, Kobayashi K, Ikeda E, Sadick M, Hebert CA, Aikawa N, Kanazawa M, and Yamaguchi K. Importance of interleukin-8 in the development of reexpansion lung injury in rabbits. Am J Respir Crit Care Med 161: 1030-1036, 2000.
126. Nibbering PH, Pos O, Stevenhagen A, and Van Furth R. Interleukin-8 enhances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes. Infect Immun 61: 3111-3116, 1993.
127. Niu JO, Munshi UK, Siddiq MM, and Parton LA. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. J Pediatr 132: 965-970, 1998.
128. Oppenheim JJ, Zachariae CO, Mukaida N, and Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9: 617-648, 1991.
129. Padrines M, Wolf M, Walz A, and Baggiolini M. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett 352: 231-235, 1994.
130. Paolini JF, Willard D, Consler T, Luther M, and Krangel MS. The chemokines IL-8, monocyte chemoattractant protein-1, and I-309 are monomers at physiologically relevant concentrations. J Immunol 153: 2704-2717, 1994.
131. Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, and Schall TJ. Cytomegalovirus encodes a potent α-chemokine. Proc Natl Acad Sci USA 96: 9839-9844, 1999.
132. Polyak SJ, Khabar KS, Paschal DM, Ezelle HJ, Duverlie G, Barber GN, Levy DE, Mukaida N, and Gretch DR. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 75: 6095-6106, 2001.
133. Polyak SJ, Khabar KS, Rezeiq M, and Gretch DR. Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol 75: 6209-6211, 2001.
134. Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M, and Clark-Lewis I. Neutrophil activation by monomeric interleukin-8. Science 264: 90-92, 1994.
135. Redl H, Schlag G, Bahrami S, Schade U, Ceska M, and Stutz P. Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model. J Infect Dis 164: 383-388, 1991.
136. Richardson RM, Ali H, Tomhave ED, Haribabu B, and Snyderman R. Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity. J Biol Chem 270: 27829-27833, 1995.
137. Richardson RM, Pridgen BC, Haribabu B, Ali H, and Snyderman R. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation. J Biol Chem 273: 23830-23836, 1998.
138. Sagai M, Furuyama A, and Ichinose T. Biological effects of diesel exhaust particle (DEP). III. Pathogenesis of asthma-like symptoms in mice. Free Radic Biol Med 21: 199-209, 1996.
139. Sakito O, Kadota J, Kohno S, Abe K, Shirai R, and Hara K. Interleukin-1β, tumor necrosis factor-α, and interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 63: 42-48, 1996.
140. Samanta AK, Oppenheim JJ, and Matsushima K. Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J Biol Chem 265: 183-189, 1990.
141. Schroder JM. The monocyte -derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J Exp Med 170: 847-863, 1989.
142. Schroder JM, Mrowietz U, Morita E, and Christophers E. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 139: 3473-3483, 1987.
143. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, and Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365: 654-657, 1993.
144. Servant G, Weiner OD, Herzmark P, Balla T, Sedat JW, and Bourne HR. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 287: 1037-1040, 2000.
145. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, and Strieter RM. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179: 1409-1415, 1994.
146. St. John RC, Mizar LA, Kindt GC, Weisbrode SE, Moore SA, and Dorinsky PM. Acid aspiration-induced acute lung injury causes leukocyte-dependent systemic organ injury. J Appl Physiol 74: 1994-2003, 1994.
147. Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, and Kunkel SL. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol 57: 752-762, 1995.
148. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan SY, Roczniak S, and Shanafelt AB. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270: 27348-27357, 1995.
149. Tager AM, Wu J, and Vermeulen MW. The effects of chloride concentration on human neutrophil functions: potential relevance to cystic fibrosis. Am J Respir Cell Mol Biol 19: 643-652, 1998.
150. Takamori H, Oades ZG, Hoch OC, Burger M, and Schraufstatter IU. Autocrine growth effect of IL-8 and GROα on a human pancreatic cancer cell line, Capan-1. Pancreas 21: 52-56, 2000.
151. Takizawa H, Ohtoshi T, Kawasaki S, Kohyama T, Desaki M, Kasama T, Kobayashi K, Nakahara K, Yamamoto K, Matsushima K, and Kudoh S. Diesel exhaust particles induce NF-κB activation in human bronchial epithelial cells in vitro: importance in cytokine transcription. J Immunol 162: 4705-4711, 1999.
152. Tsai WC, Strieter RM, Wilkowski JM, Bucknell KA, Burdick MD, Lira SA, and Standiford TJ. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J Immunol 161: 2435-2440, 1998.
153. Van Damme J, Decock B, Conings R, Lenaerts JP, Opdenakker G, and Billiau A. The chemotactic activity for granulocytes produced virally by infected fibroblasts is identical to monocyte-derived interleukin 8. Eur J Immunol 19: 1189-1194, 1989.
154. Van Damme J, Rampart M, Conings R, Decock B, Van Osselaer N, Willems J, and Billiau A. The neutrophil-activating proteins interleukin 8 and β-thromboglobulin: in vitro and in vivo comparison of amino-terminally processed forms. Eur J Immunol 20: 2113-2118, 1990.
155. Van Damme J, Van Beeumen J, Conings R, Decock B, and Billiau A. Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of β-thromboglobulin. Eur J Biochem 181: 337-344, 1989.
156. Van Zee KJ, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, Lowry SF, and Moldawer LL. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 146: 3478-3482, 1991.
157. Walter S, Bottazzi B, Govoni D, Colotta F, and Mantovani A. Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/ JE. Int J Cancer 49: 431-435, 1991.
158. Warringa RA, Koenderman L, Kok PT, Kreukniet J, and Bruijnzeel PL. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood 77: 2694-2700, 1991.
159. Warringa RA, Mengelers HJ, Raaijmakers JA, Bruijnzeel PL, and Koenderman L. Inhibition of cytokine-primed eosinophil chemotaxis by nedocromil sodium. J Allergy Clin Immunol 91: 1198-1205, 1993.
160. Watson JB, Getzler SB, and Mosher DF. Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. J Clin Invest 94: 261-268, 1994.
161. Welbourn CR, Goldman G, Paterson IS, Valeri CR, Shepro D, and Hechtman HB. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg 78: 651-655, 1991.
162. Xu L, Xie K, Mukaida N, Matsushima K, and Fidler IJ. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res 59: 5822-5829, 1999.
163. Yamamoto C, Yoneda T, Yoshikawa M, Fu A, Tokuyama T, Tsukagoshi K, and Narita N. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 112: 505-510, 1997.
164. Yang TY, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M, Sullivan L, Jenh CH, Narula SK, Chensue SW, and Lira SA. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191: 445-454, 2000.
165. Yokoi K, Mukaida N, Harada A, Watanabe Y, and Matsushima K. Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8. Lab Invest 76: 375-384, 1997.
166. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, and Leonard EJ. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84: 9233-9237, 1987.
167. Yoshimura T, Robinson EA, Appella E, Matsushima K, Showalter SD, Skeel A, and Leonard EJ. Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. Mol Immunol 26: 87-93, 1989.
168. Ziegenhagen MW, Zabel P, Zissel G, Schlaak M, and Muller-Qernheim J. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med 157: 762-768, 1998.
169. Zlotnik A and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2000.